Kennedy-Wilson (KW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
17 Feb, 2026Executive summary
Entered into a merger agreement with a consortium led by Fairfax Financial Holdings, Bill McMorrow, and senior executives, announced on February 16, 2026.
Transaction expected to close in the second quarter of 2026, subject to customary closing conditions including stockholder and regulatory approvals.
Focus remains on business continuity and supporting employees, clients, and partners during the transition.
Forward-looking statements highlight risks such as failure to obtain approvals, disruption to operations, and potential litigation.
Voting matters and shareholder proposals
Stockholders will be asked to approve the merger at a special meeting; details to be provided in the Definitive Proxy Statement.
If the merger is completed, stockholders will no longer have equity interest or rights to future earnings.
Board of directors and corporate governance
Certain directors, executive officers, and employees may be considered participants in the proxy solicitation for the merger.
Updated information on directors' and officers' interests will be disclosed in the Definitive Proxy Statement.
Latest events from Kennedy-Wilson
- Q1 2026 net income rebounded to $13.7M, with a take-private merger and EBITDA up 44%.KW
Q1 20267 May 2026 - Q1 2026 marked a return to profitability and progress toward a strategic merger.KW
Proxy filing6 May 2026 - Shareholders to vote on $10.90/share cash merger, taking the company private at a 45.9% premium.KW
Proxy filing5 May 2026 - Shareholders to vote on a $10.90 per share cash merger, taking the company private at a 45.9% premium.KW
Proxy filing27 Apr 2026 - Merger expected in Q2 2026 will eliminate all stockholder equity interests if completed.KW
Proxy filing31 Mar 2026 - Special meeting to vote on $10.90/share go-private merger, with board and committee support.KW
Proxy filing20 Mar 2026 - Merger amendment requires enhanced shareholder approval and clarifies anti-takeover provisions.KW
Proxy Filing16 Mar 2026 - Exchange offers and a management-led merger may end all stockholder equity rights if approved.KW
Proxy Filing2 Mar 2026 - Q4-25 delivered $29.6M net income, $179M adjusted EBITDA, and a pending $10.90/share buyout.KW
Q4 202525 Feb 2026